Supporting individuals using medications for opioid use disorder in recovery residences : challenges and opportunities for addressing the opioid epidemic
Full and partial opioid agonists and opioid antagonist medications play an important role in containing the opioid epidemic. However, these medications have not been used to their full extent. Recovery support services, such as recovery residences (RRs), also play a key role. RRs may increase an individual's recovery capital, facilitate social support for abstinence, and foster a sense of community among residents. These processes may be critical for individuals with opioid use disorder (OUD). In combination these two recovery pathways have the potential to enhance one another and improve outcomes among residents with OUD. Barriers to doing so have resulted in a limited supply of residences that can support residents using opioid agonist and antagonist medications. This perspective describes key interpersonal and structural barriers to medication use among individuals with an OUD seeking support from a recovery residence and discusses measures for reducing these barriers. These measures include workforce development to address stigma and attitudinal barriers and enhancing residence capability to ensure resident safety and reduce potential diversion. The perspective also highlights the need for additional research to facilitate the identification of best practices to improve outcomes among residents treated with medications living in recovery residences.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
|---|---|
| Enthalten in: |
The American journal of drug and alcohol abuse - 46(2020), 3 vom: 03. Mai, Seite 266-272 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Miles, Jennifer [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 11.01.2021 Date Revised 03.05.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/00952990.2020.1719410 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM306840812 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM306840812 | ||
| 003 | DE-627 | ||
| 005 | 20231225124246.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/00952990.2020.1719410 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1022.xml |
| 035 | |a (DE-627)NLM306840812 | ||
| 035 | |a (NLM)32091262 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Miles, Jennifer |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Supporting individuals using medications for opioid use disorder in recovery residences |b challenges and opportunities for addressing the opioid epidemic |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.01.2021 | ||
| 500 | |a Date Revised 03.05.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Full and partial opioid agonists and opioid antagonist medications play an important role in containing the opioid epidemic. However, these medications have not been used to their full extent. Recovery support services, such as recovery residences (RRs), also play a key role. RRs may increase an individual's recovery capital, facilitate social support for abstinence, and foster a sense of community among residents. These processes may be critical for individuals with opioid use disorder (OUD). In combination these two recovery pathways have the potential to enhance one another and improve outcomes among residents with OUD. Barriers to doing so have resulted in a limited supply of residences that can support residents using opioid agonist and antagonist medications. This perspective describes key interpersonal and structural barriers to medication use among individuals with an OUD seeking support from a recovery residence and discusses measures for reducing these barriers. These measures include workforce development to address stigma and attitudinal barriers and enhancing residence capability to ensure resident safety and reduce potential diversion. The perspective also highlights the need for additional research to facilitate the identification of best practices to improve outcomes among residents treated with medications living in recovery residences | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Recovery | |
| 650 | 4 | |a implementation | |
| 650 | 4 | |a opioid agonist therapy | |
| 650 | 4 | |a opioid use disorder | |
| 650 | 4 | |a policy | |
| 650 | 4 | |a recovery residence | |
| 650 | 7 | |a Narcotic Antagonists |2 NLM | |
| 650 | 7 | |a Buprenorphine |2 NLM | |
| 650 | 7 | |a 40D3SCR4GZ |2 NLM | |
| 650 | 7 | |a Naltrexone |2 NLM | |
| 650 | 7 | |a 5S6W795CQM |2 NLM | |
| 700 | 1 | |a Howell, Jason |e verfasserin |4 aut | |
| 700 | 1 | |a Sheridan, Dave |e verfasserin |4 aut | |
| 700 | 1 | |a Braucht, George |e verfasserin |4 aut | |
| 700 | 1 | |a Mericle, Amy |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The American journal of drug and alcohol abuse |d 1993 |g 46(2020), 3 vom: 03. Mai, Seite 266-272 |w (DE-627)NLM000265578 |x 1097-9891 |7 nnns |
| 773 | 1 | 8 | |g volume:46 |g year:2020 |g number:3 |g day:03 |g month:05 |g pages:266-272 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/00952990.2020.1719410 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 46 |j 2020 |e 3 |b 03 |c 05 |h 266-272 | ||